Report Company Directory

Erajaya Swasembada

• Regional Morning Meeting Notes: Thursday, September 18, 2025 by UOB
• Erajaya Swasembada (ERAA IJ) - Solid Momentum In 2H25 And Vertical Growth Commitments by UOB
• Indonesia Daily - Thursday, September 18, 2025 by UOB
• Erajaya Swasembada (ERAA IJ) - Aiming To Be The New King Of Retail by UOB
• Indonesia Daily - Thursday, August 21, 2025 by UOB
• Regional Morning Meeting Notes: Thursday, August 21, 2025 by UOB
• Erajaya Swasembada (ERAA IJ) (Buy) - Eyeing the next catalyst by Nomura Research
• Regional Morning Meeting Notes: Monday, July 28, 2025 by UOB
• Consumer – 2Q25 Preview: Mixed Results by UOB
• Indonesia Daily - Monday, July 28, 2025 by UOB

Eramet

• Eramet : Excellent 2017 results, upgrading our shadow rating. New strategic plan. by Oddo BHF
• Eramet : Excellents résultats 2017, upgrade de notre rating estimé. Nouveau plan stratégique. by Oddo BHF
• Analyse court terme - ERAMET : La moyenne mobile, haussière, confirme notre avis. by Day By Day
• Short term view - ERAMET : The rising moving average confirms our opinion. by Day By Day

Eramet SA

• Credit Morning 09/18/2025 by Oddo BHF
• Morning Crédit 18/09/2025 by Oddo BHF
• ODDO BHF SECURITIES Small & MIDCAP MORNING NEWS – 09/18/2025 by Oddo BHF
• ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 09/18/2025 by Oddo BHF
• ODDO BHF SECURITIES Small & MIDCAP MORNING NEWS – 18/09/2025 by Oddo BHF
• ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 18/09/2025 by Oddo BHF
• ODDO : US rate cuts, Anglo-Teck merger, new Aperam CEO, Eramet roadshow by Oddo BHF
• ODDO : US rate cuts, Anglo-Teck merger, new Aperam CEO, Eramet roadshow by Oddo BHF
• Moody's Ratings downgrades Eramet to B1 from Ba3; outlook remains negative by Moody's Investors Service
• MINING NOTE, BHP, MT, EU SAFEGUARDS, CHINA HOUSING, STRATEGY by BNP Paribas Exane

ERANSUS INV XXI SICAV SA

ERASCA INC

• Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference by GlobeNewsWire
• Erasca Reports Second Quarter 2025 Business Updates and Financial Results by GlobeNewsWire
• Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001 by GlobeNewsWire
• Erasca to Present at Upcoming Investor Conferences in June by GlobeNewsWire
• Erasca Reports First Quarter 2025 Business Updates and Financial Results by GlobeNewsWire
• Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway by GlobeNewsWire
• Erasca to Present at the Bank of America Securities Health Care Conference by GlobeNewsWire
• Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting by GlobeNewsWire
• Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting by GlobeNewsWire
• Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results by GlobeNewsWire